GIM
BIIB icon

Greylin Investment Management’s Biogen BIIB Stock Holding History

Greylin Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-750
Closed -$218K – 77
2018
Q2 		$218K Sell
750
-15
-2% -$4.22K 0.05% 79
2018
Q1 		$209K Sell
765
-3,725
-83% -$1.16M 0.05% 77
2017
Q4 		$1.43M Sell
4,490
-100
-2% -$32.1K 0.31% 36
2017
Q3 		$1.44M Sell
4,590
-100
-2% -$29.6K 0.33% 36
2017
Q2 		$1.27M Buy
4,690
+225
+5% +$59.5K 0.29% 35
2017
Q1 		$1.22M Buy
+4,465
New +$1.26M 0.28% 36

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Greylin Investment Management's BIIB Position: Q3 2018 in Review

Greylin Investment Management sold out of Biogen (BIIB) in Q3 2018, closing a stake of 750 shares — an estimated $218K sold.

Greylin Investment Management first reported a position in BIIB in Q1 2017 and held it in 6 quarters. The position peaked at $1.44M in Q3 2017. 1,146 funds tracked by Wall St. Rank hold BIIB as of Q3 2018.

  • Greylin Investment Management reported no remaining Biogen position as of Q3 2018 after selling out during the quarter.
  • Greylin Investment Management sold 750 Biogen shares in Q3 2018, an estimated $218K.
  • Greylin Investment Management first reported a position in Biogen in Q1 2017 and held it in 6 quarters.
  • Greylin Investment Management's Biogen position peaked at $1.44M in Q3 2017.
  • 1,146 funds tracked by Wall St. Rank held Biogen as of Q3 2018.

Based on Greylin Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.